Severe chronic active Epstein-Barr virus infection syndrome
about
Progress and problems in understanding and managing primary Epstein-Barr virus infectionsCharacterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United StatesRecurrent Fever in ChildrenA case of severe chronic active Epstein-Barr virus infection with T-cell lymphoproliferative disorder.Severe chronic active EBV infection in an adult patient: case report.Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay.EBV Chronic InfectionsFrom Burkitt's lymphoma to chronic active Epstein-Barr virus (EBV) infection: an expanding spectrum of EBV-associated diseases.Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line.Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?Immunologic difference between hypersensitivity to mosquito bite and hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infectionHodgkin's lymphoma, Epstein-Barr virus reactivation and fatal haemophagocytic syndrome.CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremiaProposed guidelines for diagnosing chronic active Epstein-Barr virus infection.Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus.Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases.Systemic EBV+ T-cell lymphoma in elderly patients: comparison with children and young adult patients.The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability.Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes.Evaluation of three commercial enzyme-linked immunosorbent assays and two latex agglutination assays for diagnosis of primary Epstein-Barr virus infection.Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection.Hydroa vacciniforme-like eruptions in a patient with chronic active EB virus infection.CD4-CD8- T-cell polymyositis in a patient with chronic active Epstein-Barr virus infection.Restricted diversification of T-cells in chronic active Epstein-Barr virus infection: potential inclination to T-lymphoproliferative disease.Epstein-Barr virus (EBV)-induced CD30+ natural killer cell-type malignancy resembling malignant histiocytosis: malignant transformation in chronic active EBV infection associating hypogammaglobulinemia.Chronic active Epstein-Barr virus infection in children in Japan.Possible autoimmune hepatitis induced after chronic active Epstein-Barr virus infection.Presence of natural killer-cell clones with variable proliferative capacity in chronic active Epstein-Barr virus infection.Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection.Detection of a nuclear antigen 2 (EBNA2)-variant Epstein-Barr virus strain in two siblings with fatal lymphoproliferative disease.Large-vessel arteritis associated with chronic active Epstein-Barr virus infection.Severe degenerative change of multiple organs mediated by chronic active Epstein-Barr virus infection with infected T-cell expansion.A case of a long-time survivor with chronic active Epstein-Barr virus infection.Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.Successful umbilical cord blood transplantation for severe chronic active Epstein-Barr virus infection after the double failure of hematopoietic stem cell transplantation.Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.Complete resolution of severe chronic active Epstein-Barr virus infection by cultured, activated donor T lymphocyte infusion after nonmyeloablative stem cells allografting.Marked swollen erythema of the face together with sicca syndrome as a sign for chronic active Epstein-Barr virus infection.The Epstein-Barr virus (EBV) major envelope glycoprotein gp350/220-specific antibody reactivities in the sera of patients with different EBV-associated diseases.A distinct subtype of Epstein Barr virus positive T/NK-cell lymphoproliferative disorder: Adult patients with chronic active Epstein Barr virus infection-like features.
P2860
Q24597706-A856D129-2FF3-4AB7-B1B5-89892DDF1DE2Q24617384-734603C4-6CE3-4A70-A9A2-7D0E4DE19572Q26749853-43703A6E-C5D6-41A7-B370-5189C4B38300Q33362585-23DBB34E-EECE-4CF2-B7ED-0B57A3C8D0A4Q33631625-AFA40CD8-5A88-4609-B483-AC2C42090E88Q33958107-B745212B-30C6-4326-85F1-B44B23DBE94CQ34171625-2A850985-BBD0-4375-B2F7-51D7EF060A63Q34397565-593374C2-00AF-4C27-9D0D-86A3DBB10849Q34502958-DCED9242-9E38-465F-BAC8-7DD6EDE50D6AQ34568578-C2174434-8BC4-4C4E-8315-0E4B5C98FE14Q35034767-79580188-0483-496B-BE5E-6B7814CDCA99Q35640337-A5F03D71-98CF-4AAF-BE87-294B7C80CD8AQ35803089-9156C314-BC17-43A7-B129-BD46AA4C4952Q36247163-2890728E-6E7F-4FED-AB3E-0D957E8BBB56Q36362069-3BBCCA6F-2EFE-475D-AEAE-E778FA14F70AQ36523190-76F38841-957C-4E63-AB4B-DB981D0BC4CEQ36837619-0568C94B-0477-49CA-9748-867DCFC5CD49Q38529622-C384F1F3-85BD-4A31-B56A-1821847F2CD6Q39581864-30C69CDC-2379-48B9-8859-4DA7660BD269Q40014720-43DEFB31-4A3E-417D-906C-58AA26C61854Q40289516-AD2740D6-F4DB-4326-AF5E-C24CEF2DC52BQ40558131-28EFF76F-E12D-4FA5-BC71-F1793446E0F6Q40571658-5B7E82DD-C059-4937-8930-FF0C93043C97Q40638600-03A14F77-FA2E-49B5-9F4D-35C4BFEFC27FQ40650077-8D8060F7-40B6-49D0-A596-D4841E8BF22CQ40678291-4A4C6CB3-B3CD-463E-8F9C-3E2FE896DF43Q40727297-A3E414B4-39A3-4993-9C85-7C9A0FCF0A1BQ40746520-98CE987B-E2AC-4646-924B-4B4F85242A38Q40804641-FDA0B895-E594-4C5E-98A7-694E36EFB18BQ41248404-69862FB4-BF23-44A5-90D5-1D508D246656Q41713949-D3BB588D-762F-482C-8C04-F21B2F4BDB42Q42166934-C8CA687C-7A0F-4D83-ACBC-5D70A9B5DD8DQ44159568-2C7712E4-8722-47D5-8CFA-48E9BEAA1101Q44445683-55E3B055-F2BB-41B7-9C03-6FAD5532EB46Q45423103-635B4394-F9AD-4B25-85C0-D1719431A800Q45588194-D2E6ACE2-4B53-4DF4-86FF-B90426758167Q45722889-52E0E174-4C39-4117-B65D-D01BEB862A2CQ45739310-D532CCF5-AA6C-4C12-B555-9693FD24EFCDQ45753602-FC01E14A-258C-4BDE-B7BD-18679E5C0FD2Q47565503-CF796D2A-6028-4A97-A9FC-7DDC3FCF5B0D
P2860
Severe chronic active Epstein-Barr virus infection syndrome
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Severe chronic active Epstein-Barr virus infection syndrome
@ast
Severe chronic active Epstein-Barr virus infection syndrome
@en
type
label
Severe chronic active Epstein-Barr virus infection syndrome
@ast
Severe chronic active Epstein-Barr virus infection syndrome
@en
prefLabel
Severe chronic active Epstein-Barr virus infection syndrome
@ast
Severe chronic active Epstein-Barr virus infection syndrome
@en
P2093
P2860
P356
P1476
Severe chronic active Epstein-Barr virus infection syndrome
@en
P2093
P2860
P304
P356
10.1128/CMR.4.1.129
P407
P577
1991-01-01T00:00:00Z